is semaglutide safe while breastfeeding Subcutaneous during Breastfeeding: Infant Safety Regarding Drug Transfer into Human Milk Semaglutide - Drugs and Lactation

The retention and bioavailability of It can shift depending on the shape in which it is expended

Singh, C., Parsad, D., Kanwar, A

Br J Pharmacol 2000

Wegovy (semaglutide) is a GLP-1 receptor agonist that slows gastric emptying, potentially exacerbating pre-existing gastric conditions Common gastrointestinal side effects include nausea (44%), vomiting (24%), dyspepsia, abdominal pain, and constipation Gastritis is not listed as a recognised adverse effect in the UK Summary of Product Characteristics Patients with severe gastrointestinal disease or history of peptic ulcer disease should discuss risks with their prescriber before starting treatment Seek urgent medical advice for severe abdominal pain, vomiting blood, black stools, or persistent symptoms that do not improve Table of Contents Can Wegovy Cause Gastritis